Australia: Alnylam Pharmaceuticals Owns Trademark for 'SIRELIS'

Australia, July 28 -- Alnylam Pharmaceuticals Inc., owns the trademark (2635019) for 'SIRELIS' till Jan. 26, 2036.

Status: protected: Registered/protected

Classes: 40 [Providing technical information in the field of pharmaceutical manufacturing; manufacturing services for others in the field of sirna synthesis; custom manufacture of sirna therapeutics; custom manufacture of rna utilizing proprietary enzymatic technologies to enable nucleic acid therapeutics development.] and 42 [Scientific research and development; research and development of small molecule RNA drugs; research and development of siRNA drugs; RNA interference technology research.]

Type of Mark: Word

Date of Acceptance: April 10

Registration Advertised: July 27

For further details contact Sarah Anne Keefe Womble Bond Dickinson (US) LLP .

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2635019.

Disclaimer: Curated by HT Syndication.